Skip to main content

Table 2 Significant bacterial isolates from specimens submitted during work up for suspected HAI

From: Prospective surveillance of healthcare associated infections in a Cambodian pediatric hospital

Organism Sample type Syndrome Sensitivity to 3GC Empirical Rx Empirical Rx changed
Acinetobacter baumanii ETT VAP R Imi/mero No
Acinetobacter baumanii B/C VAP R Ceftriaxone Yes
Coliforma B/C Gastro S Imi/mero No
Enterobacter cloacae B/C Primary BSI R Imi/mero No
Enterobacter cloacae B/C Gastro S Imi/mero No
Enterobacter cloacae B/C Line R Imi/mero No
Escherichia coli Urine UTI R Imi/mero No
Escherichia coli B/C & urine UTI R Imi/mero No
Escherichia coli Pseudomonas aeruginosa B/C NEC S
Int-R
Imi/mero No
Klebsiella pneumoniae B/C HAP R Imi/mero No
Klebsiella pneumoniae B/C VAP R Imi/mero No
Moraxella catarrhalis B/C HAP S Ceftriaxone No
Staphylococcus aureus (MRSA) B/C SSTI R Imi/mero Yes
Stenotrophomonas maltophilia Enterococcus species B/C NEC Int-R
Int-R
Imi/mero Yes
Streptococcus pyogenes B/C SSTI S Cloxacillin Yes
Yeast B/C Gastro Int-R Ceftriaxone Yes
  1. 3GC third generation cephalosporin, B/C blood culture, BSI blood stream infection, ETT endotracheal tube secretions, Gastro gastroenteritis, HAP hospital-acquired pneumonia, Imi/mero carbapenem (imipenem or meropenem), Int-R intrinsically resistant, MRSA methicillin resistant Staphylococcus aureus, NEC necrotizing enterocolitis, R resistant, Rx treatment, S sensitive, SSTI skin and soft tissue infection, UTI urinary tract infection, VAP ventilator-associated pneumonia,
  2. aThis coliform could not be identified to a satisfactory level using the biochemistry short set or bioMerieux API kits available at AHC